"RIV/00064173:_____/12:43897537!RIV13-MZ0-00064173" . . . "http://www.linkos.cz/files/klinicka-onkologie/170/3963.pdf" . "Zmrhal, Jan" . . "Improvement in early diagnostics and treatment options led to an increase in the number of young oncological patients in reproductive age. These young oncological patiens have life-long consequences of treatment, such as infertility, early menopause and sexual dysfunctions. There is the possibility of maintening fertility by assisted reproduction methods. So far, ovarian stimulation followed by ICSI and cryopreservation of embryos seem to be the most successful method. Unfortunately, this method is suitable only for patients with a stable partner where there is no risk of delay because of necessary stimulation of ovulation. For patients without a partner, it is possible to freeze stimulated oocytes. Cryopreservation of immature oocytes followed by in vitro maturation seems to be a very promising method. Freezing ovarial tissues followed by transplantation is at this point only an experimental procedure. The authors present their experience with in vitro maturation of oocytes of 28 women with pregnancy rate 14.3%. Twenty-seven cases of infertility with a high risk of ovarial hyperstimulation syndrome and one case of breast cancer patient before chemotherapy were chosen for IVM"@en . . "Reproduk\u010Dn\u00ED funkce u onkologick\u00FDch pacientek"@cs . "25" . "8"^^ . . "[F7DFD91D92A4]" . . "radiotherapy; chemotherapy; cancer; assisted reproduction techniques; fertilization in vitro; fertility"@en . "Reproductive functions in women after cancer therapy"@en . "6"^^ . . . "Zlep\u0161en\u00EDm v\u010Dasn\u00E9 diagnostiky a mo\u017Enost\u00ED l\u00E9\u010Dby se zvy\u0161uje procento p\u0159e\u017Eiv\u0161\u00EDch mlad\u00FDch onkologick\u00FDch pacient\u016F v reproduk\u010Dn\u00EDm v\u011Bku. Tyto pacienti si celo\u017Eivotn\u011B nesou d\u016Fsledky l\u00E9\u010Dby, zejm\u00E9na na reproduk\u010Dn\u00ED funkce, jedn\u00E1 se o neplodnost, p\u0159ed\u010Dasnou menopauzu a sexu\u00E1ln\u00ED dysfunkce. T\u011Bmto pacientk\u00E1m m\u00E1me mo\u017Enost nab\u00EDdnout zachov\u00E1n\u00ED plodnosti i pomoc\u00ED metod asistovan\u00E9 reprodukce. Metodou s nejvy\u0161\u0161\u00ED \u00FAsp\u011B\u0161nost\u00ED je stimulace ovari\u00ED, s n\u00E1sledn\u00FDm ICSI a zmra\u017Een\u00EDm embry\u00ED. Metoda je v\u0161ak vhodn\u00E1 jenom pro pacientky se st\u00E1l\u00FDm partnerem, u kter\u00FDch nehroz\u00ED riziko z prodlevy kv\u016Fli nutn\u00E9 stimulaci ovulace. U pacientek bez partnera je mo\u017En\u00E9 zmrazit stimulovan\u00E9 oocyty. Jako velice slibn\u00E1 a m\u00E1lo zat\u011B\u017Euj\u00EDc\u00ED metoda se jev\u00ED odb\u011Br a zmra\u017Een\u00ED nezral\u00FDch oocyt\u016F s n\u00E1sledn\u00ED in vitro maturac\u00ED. Zmra\u017Een\u00E9 ovari\u00E1ln\u00ED tk\u00E1n\u011B s n\u00E1slednou transplantac\u00ED nutno zat\u00EDm pova\u017Eovat za metodu experiment\u00E1ln\u00ED. Auto\u0159i uv\u00E1d\u00ED i sv\u00E9 zku\u0161enosti s in vitro maturac\u00ED oocyt\u016F u 28 \u017Een s pregnancy rate - 14,3 %. Indikac\u00ED k IVM byla v 27 p\u0159\u00EDpadech neplodnost s vysok\u00FDm rizikem ovari\u00E1ln\u00EDho hyperstimula\u010Dn\u00EDho syndromu, v jednom p\u0159\u00EDpad\u011B se jednalo o pacientku p\u0159ed chemoterapi\u00ED pro karcinom prsu" . . "CZ - \u010Cesk\u00E1 republika" . "Feldm\u00E1r, Peter" . . . "5"^^ . . . "Reproduk\u010Dn\u00ED funkce u onkologick\u00FDch pacientek"@cs . . "I" . "Kosov\u00E1, Tereza" . . . "3" . . "Klinick\u00E1 onkologie" . . . "Ku\u010Dera, Eduard" . "Goji\u0161, Ond\u0159ej" . . "Zlep\u0161en\u00EDm v\u010Dasn\u00E9 diagnostiky a mo\u017Enost\u00ED l\u00E9\u010Dby se zvy\u0161uje procento p\u0159e\u017Eiv\u0161\u00EDch mlad\u00FDch onkologick\u00FDch pacient\u016F v reproduk\u010Dn\u00EDm v\u011Bku. Tyto pacienti si celo\u017Eivotn\u011B nesou d\u016Fsledky l\u00E9\u010Dby, zejm\u00E9na na reproduk\u010Dn\u00ED funkce, jedn\u00E1 se o neplodnost, p\u0159ed\u010Dasnou menopauzu a sexu\u00E1ln\u00ED dysfunkce. T\u011Bmto pacientk\u00E1m m\u00E1me mo\u017Enost nab\u00EDdnout zachov\u00E1n\u00ED plodnosti i pomoc\u00ED metod asistovan\u00E9 reprodukce. Metodou s nejvy\u0161\u0161\u00ED \u00FAsp\u011B\u0161nost\u00ED je stimulace ovari\u00ED, s n\u00E1sledn\u00FDm ICSI a zmra\u017Een\u00EDm embry\u00ED. Metoda je v\u0161ak vhodn\u00E1 jenom pro pacientky se st\u00E1l\u00FDm partnerem, u kter\u00FDch nehroz\u00ED riziko z prodlevy kv\u016Fli nutn\u00E9 stimulaci ovulace. U pacientek bez partnera je mo\u017En\u00E9 zmrazit stimulovan\u00E9 oocyty. Jako velice slibn\u00E1 a m\u00E1lo zat\u011B\u017Euj\u00EDc\u00ED metoda se jev\u00ED odb\u011Br a zmra\u017Een\u00ED nezral\u00FDch oocyt\u016F s n\u00E1sledn\u00ED in vitro maturac\u00ED. Zmra\u017Een\u00E9 ovari\u00E1ln\u00ED tk\u00E1n\u011B s n\u00E1slednou transplantac\u00ED nutno zat\u00EDm pova\u017Eovat za metodu experiment\u00E1ln\u00ED. Auto\u0159i uv\u00E1d\u00ED i sv\u00E9 zku\u0161enosti s in vitro maturac\u00ED oocyt\u016F u 28 \u017Een s pregnancy rate - 14,3 %. Indikac\u00ED k IVM byla v 27 p\u0159\u00EDpadech neplodnost s vysok\u00FDm rizikem ovari\u00E1ln\u00EDho hyperstimula\u010Dn\u00EDho syndromu, v jednom p\u0159\u00EDpad\u011B se jednalo o pacientku p\u0159ed chemoterapi\u00ED pro karcinom prsu"@cs . . . "RIV/00064173:_____/12:43897537" . "165085" . "Reproductive functions in women after cancer therapy"@en . "Reproduk\u010Dn\u00ED funkce u onkologick\u00FDch pacientek" . "Bendov\u00E1, Marie" . . "0862-495X" . "Z\u00E1humensk\u00FD, Jozef" . "Reproduk\u010Dn\u00ED funkce u onkologick\u00FDch pacientek" .